Collectively, these results revealed that the loss of ATRX in both MYCN-amplified and MYCN single copy TP53 wt NB cells promoted the accumulation of DNA damage and activated the cell cycle checkpoint pathway of DDR, the ATM-CHK2-p53-p21 pathway, leading to cell cycle arrest. The gene discussed is CHEK2; the disease is neuroblastoma.